Inhalte im Video:

00:00

“Neurostimulation is an option for patients who don’t respond or are intolerant to current acute or preventive therapies”

00:40

Single-pulse transcranial magnetic stimulation: Availability in Europe, and why they are particularly favorable for young women

01:51

Effect sizes of neurostimulation treatments for acute or preventive treatment of migraine

03:27

History of treatments, and neurological and physiological manifestations help guide patient selection for neurostimulation

04:46

How CE marketing in Europe works for medical devices, such as neurostimulation devices.

Interview mit:

Dr. Peter Goadsby

Interview von:

Produziert von:

Christophe Vandenbussche

1. Juli 2019Dr. Peter Goadsby

EAN 2019: „Neuromodulation part of the future of migraine treatment”

Dr. Peter Goadsby, King’s College, London, UK, about Single-pulse transcranial magnetic stimulation and Non-invasive Vagus Nerve Stimulation: their availability in Europe, and which patients should receive them.